Clinical Trials
43 trialsRITUXIMAB BS Intravenous Infusion 100mg・500mg [Pfizer] Post-marketing Database Study
Pfizer
Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC
AIDS Malignancy Consortium
VIRAL
Children's Hospital of Philadelphia
Besponsa Post Marketing Surveillance Study
Pfizer
BESPONSA Injection 1 mg Special Investigation
Pfizer
PRIORITY
Institut Bergonié
URBAN
Hoffmann-La Roche
LOYAL
Pfizer
A Study of Patients Who Received Inotuzumab Ozogamicin for B-cell ALL (Acute Lymphoblastic Leukemia) That Occurred Again After the Last Treatment
Pfizer
Understanding What Matters Most to Patients: Establishing the Validity of a Best-Worst Scaling Survey
UNC Lineberger Comprehensive Cancer Center
POGO
Edwards Lifesciences
Special Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion "Relapsed or Refractory CD30-positive Peripheral T Cell Lymphoma or Pediatric Hodgkin Lymphoma"
Takeda
STAR-TOR
Pfizer
MOSAIC
Imperial College London
Shoulder Instability in Children: Muscle Activity and Movement
Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust
VircapSeq Virus Detection in Sézary Syndrome
Columbia University
Cardiac Magnetic Resonance Imaging in Patients With Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorubicin
University of Nebraska
Chemobrain
University of Nebraska
Non-Interventional Study to Examine Rituximab Treatment in Follicular Lymphoma Participants
Hoffmann-La Roche
Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies
AIDS Malignancy Consortium
InO
Pfizer
PHRC2003
Institut Bergonié
QS-SID
AIO-Studien-gGmbH
18F-FDG PET Radiomics of Diffuse Large B-cell Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
Brentuximab Vedotin (Recombinant) for IV Infusion - Special Drug Use Surveillance (All-case Surveillance) "Relapsed or Refractory CD30+ Hodgkin's Lymphoma or Anaplastic Large Cell Lymphoma"
Takeda
PROVe
Helsinn Therapeutics (U.S.), Inc
A Retrospective, Open-label, Uncontrolled Cohort Study to Assess the Effectiveness and Safety of Lactulose Retention Enema in the Treatment of Cirrhotic Patients With Grade 3 or 4 (West Haven Criteria) Hepatic Encephalopathy (HE) [The RETRO Study]
Abbott
A Study on Rituximab (MabThera) in Participants With Chronic Lymphocytic Leukemia (CLL)
Hoffmann-La Roche
Iodine I 131 Tositumomab or Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
CaLLypso
Hoffmann-La Roche
Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic Stem Cell Transplantation
National Institutes of Health Clinical Center (CC)
REFLECT 2
Hoffmann-La Roche
Phase 2 Total Skin Electron Beam Therapy (TSEBT 12 Gy) in Stage IB-IIIA Mycosis Fungoides
Stanford University
dMRI
University of Michigan Rogel Cancer Center
Use of Saline-Washed Platelet and Red Cell Transfusions in Adult Acute Leukemia
University of Rochester
Patient Registry to Observe Outcomes Following Implantation of the VariLift Interbody Fusion Device
Wenzel Spine
INHIBITOR: Retrospective Study Of Patients With Renal Cell Carcinoma And Mantle Cell Lymphoma Treated With Temsirolimus
Pfizer
PRO-R-IPI
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Prospective Observational Study on the Management of Patients With Relapsed or Refractory Follicular Lymphoma (OLYMPE)
Hoffmann-La Roche
MabThera (Rituximab) in Combination With CHOP (or CHOP-like) Chemotherapy in Patients With Aggressive B-Cell Lymphoma
Hoffmann-La Roche
Monitor-GCSF
Sandoz
Rituximab Therapy in Follicular Lymphoma in Combination With Chemotherapy - REFLECT 1
Hoffmann-La Roche
Methylation of p16 CpG Island And Malignant Transformation of Oral Epithelial Dysplasia
Peking University